VEGFA and hepatocellular carcinoma: As shown in Figures 5A, B, in the high-risk HCC group, aberrant DNA replication and recombination, epigenetic dysregulation, cell cycle chaos, and activation of oncogenic signaling pathways such as MAPK, mTOR, and VEGF were obviously enriched.